{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T20:27:41Z","timestamp":1794860861327,"version":"4.9.1"},"reference-count":236,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:p>The central cholinergic system plays a crucial role in neural communication and physiological regulation, mediated by acetylcholine (ACh) and cholinergic receptors in the central nervous system (CNS). In this review, we explore the extensive distribution and impact of the central cholinergic system and its pivotal involvement in Parkinson's disease (PD). Despite PD being traditionally perceived as primarily a dopaminergic disorder, it exhibits significant cholinergic alterations, contributing to both motor and non-motor symptoms. These PD-specific alterations manifest as neuroanatomical changes, diminished acetylcholinesterase activity, and functional disturbances across various brain regions, impacting cognition, mood, sensory perception, sleep, and motor function. Comprehension of these cholinergic dysfunctions is paramount for the development of targeted therapies aimed at alleviating these PD symptoms. To provide further insight, we explore the therapeutic potential of nicotinic acetylcholine receptors (nAChRs) in PD, highlighting their role in preventing apoptosis, modulating neuroinflammation, and mitigating CNS damage. In summary, this review underscores the critical importance of cholinergic mechanisms in PD pathology and champions cholinergic-based interventions for enhanced patient outcomes and improved quality of life.<\/jats:p>","DOI":"10.1177\/1877718x261427270","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:39:43Z","timestamp":1773916783000},"page":"391-415","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["The central cholinergic system as a therapeutic target in Parkinson's disease"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1432-9547","authenticated-orcid":false,"given":"Sean J","family":"Miller","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8796-7816","authenticated-orcid":false,"given":"Johnny S","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suleyman B","family":"Bozal","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, USA"},{"name":"Department of Biomedical Engineering, Yale University, Yale School of Medicine, New Haven, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3368-239X","authenticated-orcid":false,"given":"Robert","family":"Logan","sequence":"additional","affiliation":[{"name":"Department of Biology and Biotechnology, Endicott College, Beverly, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P","family":"Hafler","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, USA"},{"name":"Department of Pathology, Yale University School of Medicine, New Haven, USA"},{"name":"Broad Institute of MIT and Harvard, Cambridge, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00005107"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.5272\/jimab.2022284.4671"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.2174\/092986708783503203"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biophys.32.110601.142536"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/35077011"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.2174\/157015907781695946"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4295"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.3390\/60300142"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1529\/biophysj.104.049726"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2007.07.001"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.irn.2015.07.001"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68947-7"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134434"},{"key":"e_1_3_3_15_2","first-page":"825","article-title":"The distribution of cholinergic neurons in the human central nervous system","volume":"15","author":"Oda Y","year":"2000","unstructured":"Oda Y, Nakanishi I. The distribution of cholinergic neurons in the human central nervous system. Histol Histopathol 2000; 15: 825\u2013834.","journal-title":"Histol Histopathol"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6123(08)60908-5"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2009.02.044"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2014.04.026"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fncir.2021.701080"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00221-022-06354-2"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2016.09.006"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1101\/2020.11.07.372649"},{"key":"e_1_3_3_23_2","first-page":"175","article-title":"The diagonal band of Broca in health and disease","author":"Liu A","year":"2021","unstructured":"Liu A, Gentleman S. The diagonal band of Broca in health and disease. Handb Clin Neurol 2021; 179: 175\u2013187.","journal-title":"Handb Clin Neurol"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12513"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32558-9"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2014.11.028"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-019-00397-2"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2022.843303"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2017.02.027"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26556"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2011.00022"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2004.07.009"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2011.07.007"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-016-1530-9"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(95)00177-K"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11557-3"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0361-9230(90)90072-8"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5071-13.2014"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2010.00137"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2014.10.054"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00148.2020"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1152\/jn.01067.2002"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72848-0"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-016-0363-y"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2013.00931"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/cne.23167"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2019.00100"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30020-9"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2009.03.085"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110882"},{"key":"e_1_3_3_51_2","first-page":"607","article-title":"Toward an understanding of the habenula\u2019s various roles in human depression","volume":"73","author":"Aizawa H","year":"2019","unstructured":"Aizawa H, Zhu M. Toward an understanding of the habenula\u2019s various roles in human depression. Psychiatry ClinThe Journal of Molecular Diagnosticshe Journal of Physical Chemistry C 2019; 73: 607\u2013612.","journal-title":"Psychiatry ClinThe Journal of Molecular Diagnosticshe Journal of Physical Chemistry C"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0127-21.2021"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70373-8"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04192.x"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20897"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22691"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx333"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2009.12.048"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120357"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.654931"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.12.1745"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(86)91401-0"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-4580(94)90054-X"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104831"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00099"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.9.1767"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2021.07.024"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.32018"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.15135"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21144918"},{"key":"e_1_3_3_72_2","first-page":"108","volume-title":"Vitro binding study using 5-[125I]-A-85380","author":"Pimlott SL","year":"2004","unstructured":"Pimlott SL, Piggott M, Owens J, et al. Nicotinic acetylcholine receptor distribution in Alzheimer\u2019s disease, dementia with Lewy bodies, Parkinson\u2019s disease, and vascular dementia. In: Vitro binding study using 5-[125I]-A-85380. 29, 108\u2013116. Neuropsychopharmacology, 2004. https:\/\/doi.org\/10.1038\/sj.npp.1300302"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20688"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00213"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.65.2.155"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.irn.2018.07.027"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abi4907"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-020-0380-z"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2012.04.038"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.261939"},{"key":"e_1_3_3_81_2","first-page":"1","article-title":"Subjective cognitive decline in patients with Parkinson\u2019s disease: an updated review","volume":"15","author":"Huang J","year":"2023","unstructured":"Huang J, Yuan X, Chen L, et al. Subjective cognitive decline in patients with Parkinson\u2019s disease: an updated review. Front Aging Neurosci 2023; 15: 1\u201313.","journal-title":"Front Aging Neurosci"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.943438"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27902"},{"key":"e_1_3_3_84_2","first-page":"1","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland D","year":"2021","unstructured":"Aarsland D, Batzu L, Halliday GM, et al. Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers 2021; 7: 1\u201321.","journal-title":"Nat Rev Dis Primers"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.13752"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1016-8"},{"key":"e_1_3_3_87_2","doi-asserted-by":"crossref","unstructured":"Wilson H de Natale ER Politis M. Nucleus basalis of Meynert degeneration predicts cognitive impairment in Parkinson\u2019s disease In Handbook of Clinical Neurology (1st ed Vol 179) Elsevier BV https:\/\/doi.org\/10.1016\/B978-0-12-819975-6.00010-8. 2021.","DOI":"10.1016\/B978-0-12-819975-6.00010-8"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.851788"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11682-023-00817-y"},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2076942"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00330-6"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00025"},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.581144"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2006.100073"},{"key":"e_1_3_3_95_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179290"},{"key":"e_1_3_3_96_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-318107"},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-212749"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.176077"},{"key":"e_1_3_3_99_2","first-page":"9","article-title":"Neurochemical features of rem sleep behaviour disorder","volume":"11","author":"Jim\u00e9nez-Jim\u00e9nez FJ","year":"2021","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Alonso-Navarro H, Garc\u00eda-Mart\u00edn E, et al. Neurochemical features of rem sleep behaviour disorder. J Pers Med 2021; 11: 9.","journal-title":"J Pers Med"},{"key":"e_1_3_3_100_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01494"},{"key":"e_1_3_3_101_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2008.153874"},{"key":"e_1_3_3_102_2","doi-asserted-by":"publisher","DOI":"10.1038\/npjparkd.2016.1"},{"key":"e_1_3_3_103_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00093.2011"},{"key":"e_1_3_3_104_2","doi-asserted-by":"publisher","DOI":"10.1177\/1756285610392446"},{"key":"e_1_3_3_105_2","doi-asserted-by":"publisher","DOI":"10.47795\/ONNS5189"},{"key":"e_1_3_3_106_2","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.13319"},{"key":"e_1_3_3_107_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199907)46:1<62::AID-ANA10>3.0.CO;2-P"},{"key":"e_1_3_3_108_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn237"},{"key":"e_1_3_3_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.visres.2015.08.011"},{"key":"e_1_3_3_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.visres.2010.08.029"},{"key":"e_1_3_3_111_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2405-16.2017"},{"key":"e_1_3_3_112_2","first-page":"1","article-title":"Starburst amacrine cells, involved in visual motion perception, loose their synaptic input from dopaminergic amacrine cells and degenerate in Parkinson\u2019s disease patients","volume":"12","author":"S\u00e1nchez-S\u00e1ez X","year":"2023","unstructured":"S\u00e1nchez-S\u00e1ez X, Ortu\u00f1o-Lizar\u00e1n I, S\u00e1nchez-Castillo C, et al. Starburst amacrine cells, involved in visual motion perception, loose their synaptic input from dopaminergic amacrine cells and degenerate in Parkinson\u2019s disease patients. Transl Neurodegener 2023; 12: 1\u201316.","journal-title":"Transl Neurodegener"},{"key":"e_1_3_3_113_2","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.13253"},{"key":"e_1_3_3_114_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1398764"},{"key":"e_1_3_3_115_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102457"},{"key":"e_1_3_3_116_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004383"},{"key":"e_1_3_3_117_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21291"},{"key":"e_1_3_3_118_2","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12050513"},{"key":"e_1_3_3_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2017.03.011"},{"key":"e_1_3_3_120_2","first-page":"134","article-title":"Olfactory dysfunction in Parkinson\u2019s disease","volume":"4","author":"Torres-Pasillas G","year":"2023","unstructured":"Torres-Pasillas G, Chi-Casta\u00f1eda D, Carrillo-Castilla P, et al. Olfactory dysfunction in Parkinson\u2019s disease. Its Functional and Neuroanatomical Correlates. NeuroSci 2023; 4: 134\u2013151.","journal-title":"Its Functional and Neuroanatomical Correlates. NeuroSci"},{"key":"e_1_3_3_121_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2017.03.049"},{"key":"e_1_3_3_122_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-019-02074-0"},{"key":"e_1_3_3_123_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq079"},{"key":"e_1_3_3_124_2","first-page":"03","article-title":"Clinical features of Parkinson\u2019s disease: the evolution of critical symptoms","volume":"9","author":"V\u00e1radi C","year":"2020","unstructured":"V\u00e1radi C. Clinical features of Parkinson\u2019s disease: the evolution of critical symptoms. Biology (Basel) 2020; 9: 03.","journal-title":"Biology (Basel)"},{"key":"e_1_3_3_125_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-023-02428-2"},{"key":"e_1_3_3_126_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20324"},{"key":"e_1_3_3_127_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-305277"},{"key":"e_1_3_3_128_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells11233736"},{"key":"e_1_3_3_129_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25430"},{"key":"e_1_3_3_130_2","doi-asserted-by":"publisher","DOI":"10.1037\/bne0000048"},{"key":"e_1_3_3_131_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.874692"},{"key":"e_1_3_3_132_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-021-00251-1"},{"key":"e_1_3_3_133_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-017-0090-8"},{"key":"e_1_3_3_134_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24012"},{"key":"e_1_3_3_135_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181ec67f1"},{"key":"e_1_3_3_136_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009437"},{"key":"e_1_3_3_137_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29707"},{"key":"e_1_3_3_138_2","first-page":"9","article-title":"Nicotine in Parkinson\u2019s disease- a therapeutic track gone up in smoke?","volume":"2","author":"Charbonneau P-F","year":"2023","unstructured":"Charbonneau P-F, Damier P. Nicotine in Parkinson\u2019s disease- a therapeutic track gone up in smoke? New England Journal of Medicine Evidence 2023; 2: 9.","journal-title":"New England Journal of Medicine Evidence"},{"key":"e_1_3_3_139_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26102"},{"key":"e_1_3_3_140_2","doi-asserted-by":"publisher","DOI":"10.1177\/1877718X241313373"},{"key":"e_1_3_3_141_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2018.12.003"},{"key":"e_1_3_3_142_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2022.07.011"},{"key":"e_1_3_3_143_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2379"},{"key":"e_1_3_3_144_2","doi-asserted-by":"publisher","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch7"},{"key":"e_1_3_3_145_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12839"},{"key":"e_1_3_3_146_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2019.0677"},{"key":"e_1_3_3_147_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910432"},{"key":"e_1_3_3_148_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00436-023-08031-x"},{"key":"e_1_3_3_149_2","doi-asserted-by":"publisher","DOI":"10.1080\/01926230701320337"},{"key":"e_1_3_3_150_2","first-page":"1","article-title":"Targeting the intrinsic apoptosis pathway: a window of opportunity for prostate cancer","volume":"14","author":"Westaby D","year":"2022","unstructured":"Westaby D, Jimenez-Vacas JM, Padilha A, et al. Targeting the intrinsic apoptosis pathway: a window of opportunity for prostate cancer. Cancers (Basel) 2022; 14: 1.","journal-title":"Cancers (Basel)"},{"key":"e_1_3_3_151_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2020.06.036"},{"key":"e_1_3_3_152_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-021-00814-y"},{"key":"e_1_3_3_153_2","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201899916"},{"key":"e_1_3_3_154_2","first-page":"1","article-title":"Activation of \u03b17-nAChRs promotes the clearance of \u03b1-synuclein and protects against apoptotic cell death induced by exogenous \u03b1-synuclein fibrils","volume":"9","author":"Zhao J","year":"2021","unstructured":"Zhao J, Li Y, Li Y, et al. Activation of \u03b17-nAChRs promotes the clearance of \u03b1-synuclein and protects against apoptotic cell death induced by exogenous \u03b1-synuclein fibrils. Front Cell Dev Biol 2021; 9: 1\u201312.","journal-title":"Front Cell Dev Biol"},{"key":"e_1_3_3_155_2","first-page":"1","article-title":"The neuroprotective effect of nicotine in Parkinson\u2019s disease models is associated with inhibiting PARP-1 and caspase-3 cleavage","volume":"2017","author":"Lu JYD","year":"2017","unstructured":"Lu JYD, Su P, Barber JEM, et al. The neuroprotective effect of nicotine in Parkinson\u2019s disease models is associated with inhibiting PARP-1 and caspase-3 cleavage. PeerJ 2017; 2017: 1\u201324.","journal-title":"PeerJ"},{"key":"e_1_3_3_156_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28484"},{"key":"e_1_3_3_157_2","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.21869"},{"key":"e_1_3_3_158_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.585584"},{"key":"e_1_3_3_159_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.600089"},{"key":"e_1_3_3_160_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-021-00278-7"},{"key":"e_1_3_3_161_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(97)00556-8"},{"key":"e_1_3_3_162_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(05)81351-8"},{"key":"e_1_3_3_163_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2927"},{"key":"e_1_3_3_164_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-10-8488-1_4"},{"key":"e_1_3_3_165_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1088957"},{"key":"e_1_3_3_166_2","doi-asserted-by":"publisher","DOI":"10.1080\/01913123.2021.2015499"},{"key":"e_1_3_3_167_2","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.23160"},{"key":"e_1_3_3_168_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphs.2024.07.008"},{"key":"e_1_3_3_169_2","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00507"},{"key":"e_1_3_3_170_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M212157200"},{"key":"e_1_3_3_171_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.30.19080"},{"key":"e_1_3_3_172_2","first-page":"2833","article-title":"Proteomics and bioinformatics approaches for the identification of plasma biomarkers to detect Parkinson's disease","volume":"18","author":"Dong W","year":"2019","unstructured":"Dong W, Qiu C, Gong D, et al. Proteomics and bioinformatics approaches for the identification of plasma biomarkers to detect Parkinson's disease. Exp Ther Med 2019; 18: 2833\u20132842.","journal-title":"Exp Ther Med"},{"key":"e_1_3_3_173_2","doi-asserted-by":"publisher","DOI":"10.18632\/aging.202181"},{"key":"e_1_3_3_174_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu281"},{"key":"e_1_3_3_175_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.12.032"},{"key":"e_1_3_3_176_2","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12040955"},{"key":"e_1_3_3_177_2","first-page":"1","article-title":"Physiologic functions and therapeutic applications of \u03b17 nicotinic acetylcholine receptor in brain disorders","volume":"15","author":"Lee CH","year":"2023","unstructured":"Lee CH, Hung SY. Physiologic functions and therapeutic applications of \u03b17 nicotinic acetylcholine receptor in brain disorders. Pharmaceutics 2023; 15: 1\u201317.","journal-title":"Pharmaceutics"},{"key":"e_1_3_3_178_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02768-z"},{"key":"e_1_3_3_179_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2020.10.027"},{"key":"e_1_3_3_180_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094912"},{"key":"e_1_3_3_181_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells13060474"},{"key":"e_1_3_3_182_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26206139"},{"key":"e_1_3_3_183_2","doi-asserted-by":"publisher","DOI":"10.1111\/cns.12758"},{"key":"e_1_3_3_184_2","first-page":"8","article-title":"Anti-Inflammatory and neuroprotective mechanisms of GTS-21, an \u03b17 nicotinic acetylcholine receptor agonist, in neuroinflammation and Parkinson\u2019s disease mouse models","volume":"23","author":"Park JE","year":"2022","unstructured":"Park JE, Leem YH, Park JS, et al. Anti-Inflammatory and neuroprotective mechanisms of GTS-21, an \u03b17 nicotinic acetylcholine receptor agonist, in neuroinflammation and Parkinson\u2019s disease mouse models. Int J Mol Sci 2022; 23: 8.","journal-title":"Int J Mol Sci"},{"key":"e_1_3_3_185_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0725-1"},{"key":"e_1_3_3_186_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0967-6"},{"key":"e_1_3_3_187_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25225474"},{"key":"e_1_3_3_188_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-98"},{"key":"e_1_3_3_189_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21203"},{"key":"e_1_3_3_190_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.140897"},{"key":"e_1_3_3_191_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.110.003269"},{"key":"e_1_3_3_192_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2014.09.015"},{"key":"e_1_3_3_193_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.4c05089"},{"key":"e_1_3_3_194_2","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.22092.1"},{"key":"e_1_3_3_195_2","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14266"},{"key":"e_1_3_3_196_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.01.013"},{"key":"e_1_3_3_197_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00726"},{"key":"e_1_3_3_198_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.1063162"},{"key":"e_1_3_3_199_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.824191"},{"key":"e_1_3_3_200_2","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.3c00531"},{"key":"e_1_3_3_201_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-022-03659-0"},{"key":"e_1_3_3_202_2","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9969842"},{"key":"e_1_3_3_203_2","first-page":"1","article-title":"Nicotine rebalances NAD+ homeostasis and improves aging-related symptoms in male mice by enhancing NAMPT activity","volume":"14","author":"Yang L","year":"2023","unstructured":"Yang L, Shen J, Liu C, et al. Nicotine rebalances NAD+ homeostasis and improves aging-related symptoms in male mice by enhancing NAMPT activity. Nat Commun 2023; 14: 1.","journal-title":"Nat Commun"},{"key":"e_1_3_3_204_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.116.307157"},{"key":"e_1_3_3_205_2","doi-asserted-by":"publisher","DOI":"10.1080\/14653240902887267"},{"key":"e_1_3_3_206_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26010101"},{"key":"e_1_3_3_207_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells9041035"},{"key":"e_1_3_3_208_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2020.152502"},{"key":"e_1_3_3_209_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-05-01709.2002"},{"key":"e_1_3_3_210_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.111.187856"},{"key":"e_1_3_3_211_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28564"},{"key":"e_1_3_3_212_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.12-09-03591.1992"},{"key":"e_1_3_3_213_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.11-10-03218.1991"},{"key":"e_1_3_3_214_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.18.10483"},{"key":"e_1_3_3_215_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0873-16.2016"},{"key":"e_1_3_3_216_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196902132800701"},{"key":"e_1_3_3_217_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adp6301"},{"key":"e_1_3_3_218_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2011.04.004"},{"key":"e_1_3_3_219_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnsyn.2014.00022"},{"key":"e_1_3_3_220_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2147780"},{"key":"e_1_3_3_221_2","first-page":"353","article-title":"Microcircuitry of the direct and indirect pathways of the basal ganglia","volume":"86","author":"Smith Y","year":"1998","unstructured":"Smith Y, Bevan MD, Shink E, et al. Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 1998; 86: 353\u2013387.","journal-title":"Neuroscience"},{"key":"e_1_3_3_222_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature09159"},{"key":"e_1_3_3_223_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2018.12.004"},{"key":"e_1_3_3_224_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111034"},{"key":"e_1_3_3_225_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2019.06.013"},{"key":"e_1_3_3_226_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI42642"},{"key":"e_1_3_3_227_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu193"},{"key":"e_1_3_3_228_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2010.00182.x"},{"key":"e_1_3_3_229_2","first-page":"1611","article-title":"Cholinesterase inhibitors and memantine for Parkinson's disease dementia and Lewy body dementia: A meta-analysis","volume":"17","author":"Meng YH","year":"2018","unstructured":"Meng YH, Wang PP, Song YX, et al. Cholinesterase inhibitors and memantine for Parkinson's disease dementia and Lewy body dementia: A meta-analysis. Exp Ther Med 2018; 17: 1611\u20131624.","journal-title":"Exp Ther Med"},{"key":"e_1_3_3_230_2","first-page":"8","article-title":"Interventions for preventing falls in Parkinson's disease","volume":"2022","author":"Allen NE","year":"2022","unstructured":"Allen NE, Canning CG, Almeida LRS, et al. Interventions for preventing falls in Parkinson's disease. Cochrane Database Syst Rev 2022; 2022: 8.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_231_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31825dcdc1"},{"key":"e_1_3_3_232_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.brs.2024.12.287"},{"key":"e_1_3_3_233_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-212793"},{"key":"e_1_3_3_234_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awl346"},{"key":"e_1_3_3_235_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25929"},{"key":"e_1_3_3_236_2","article-title":"Transdermal nicotine treatment and progression of early Parkinson\u2019s disease","volume":"2","author":"Oertel W","year":"2023","unstructured":"Oertel W, M\u00fcller H-H, Unger MM, et al. Transdermal nicotine treatment and progression of early Parkinson\u2019s disease. New England Journal of Medicine Evidence 2023; 2: EVIDoa2200311.","journal-title":"New England Journal of Medicine Evidence"},{"key":"e_1_3_3_237_2","first-page":"8","article-title":"Current therapies in clinical trials of Parkinson\u2019s disease: a 2021 update","volume":"14","author":"Maruthi Prasad E","year":"2021","unstructured":"Maruthi Prasad E, & Hung SY. Current therapies in clinical trials of Parkinson\u2019s disease: a 2021 update. Pharmaceuticals 2021; 14: 8.","journal-title":"Pharmaceuticals"}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261427270","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1877718X261427270","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261427270","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:17:38Z","timestamp":1778840258000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1877718X261427270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":236,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1177\/1877718X261427270"],"URL":"https:\/\/doi.org\/10.1177\/1877718x261427270","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]}}}